Clinical trials recruiting for Prostate Cancer Recurrent

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
  NCT05646550 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
  NCT07410494 · Phase: Phase 1, Phase 2 · Ages: 8 Years to 85 Years · Sex: All (male and female) · 3 locations
• COAST Therapy in Advanced Solid Tumors and Prostate Cancer
  NCT05036226 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
  NCT07131956 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 3 locations
• Lab Research Using Mini-tumors to Study Prostate Cancer Treatments
  NCT07004582 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 3 locations
• Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
  NCT05352178 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
  NCT05022914 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• PSMA-RLT in Biochemically Recurrent PCa
  NCT06220188 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
  NCT06957691 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 1 location
• Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
  NCT06508567 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
  NCT07690579 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location

Related conditions

Trials recruiting for Prostate Cancer Recurrent often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Prostate Cancer Recurrent trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.